Publications by authors named "Hugo Prazeres"

Claim this Profile
T
Targeting under-screened women in cervical cancer: combining self-sampling and human papillomavirus testing with a strategic reminder plan.
Sara da Graça Pereira, Luís Nobre, Marina Ribeiro, Patrícia Carvalho, Ana Morais, Hugo Prazeres

Eur J Public Health· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TERTmonitor Efficacy and Performance in Detecting Mutations by Droplet Digital PCR.
Mafalda Bessa-Gonçalves, João Paulo Brás, Tito Teles Jesus, Hugo Prazeres, Paula Soares

Genes (Basel)· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum: Evaluation of mutations in advanced ER+/HER2-breast cancer in Portugal - U-PIK Project.
Ana Peixoto, Luís Cirnes, Ana Luísa Carvalho, Maria João Andrade, Maria José Brito, Hugo Prazeres

Front Mol Biosci· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TERTmonitor-qPCR Detection of Mutations in Glioma.
João Paulo Brás, Tito Teles Jesus, Hugo Prazeres, Jorge Lima, Paula Soares

Genes (Basel)· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using a Dual CRISPR/Cas9 Approach to Gain Insight into the Role of LRP1B in Glioblastoma.
Joana Peixoto, Catarina Príncipe, Ana Pestana, Hugo Osório, Marta Teixeira Pinto, Hugo Prazeres

Int J Mol Sci· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of mutations in advanced ER+/HER2-breast cancer in Portugal - U-PIK Project.
Ana Peixoto, Luís Cirnes, Ana Luísa Carvalho, Maria João Andrade, Maria José Brito, Hugo Prazeres

Front Mol Biosci· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LRP1B Expression as a Putative Predictor of Response to Pegylated Liposomal Doxorubicin Treatment in Ovarian Cancer.
Isabel J Dionísio de Sousa, Ana Isabel Cunha, Inês A Saraiva, Raquel V Portugal, Etel R P Gimba, Hugo Prazeres

Pathobiology· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resistance to endocrine therapy in HR + and/or HER2 + breast cancer: the most promising predictive biomarkers.
Flávia Miranda, Hugo Prazeres, Fernando Mendes, Diana Martins, Fernando Schmitt

Mol Biol Rep· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LRP1B: A Giant Lost in Cancer Translation.
Catarina Príncipe, Isabel J Dionísio de Sousa, Hugo Prazeres, Paula Soares, Raquel T Lima

Pharmaceuticals (Basel)· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Validation of a Urine Test (Uromonitor-V2) for the Surveillance of Non-Muscle-Invasive Bladder Cancer Patients.
Caroline A Sieverink, Rui P M Batista, Hugo J M Prazeres, João Vinagre, Cristina Sampaio

Diagnostics (Basel)· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive Biomarkers and Patient Outcome in Platinum-Resistant (PLD-Treated) Ovarian Cancer.
Isabel J Dionísio de Sousa, Durval S Marques, Catarina Príncipe, Raquel V Portugal, Sule Canberk, Hugo Prazeres

Diagnostics (Basel)· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomarkers for Bladder Cancer Diagnosis and Surveillance: A Comprehensive Review.
Rui Batista, Nuno Vinagre, Sara Meireles, João Vinagre, Hugo Prazeres

Diagnostics (Basel)· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of a Novel, Sensitive, and Specific Urine-Based Test for Recurrence Surveillance of Patients With Non-Muscle-Invasive Bladder Cancer in a Comprehensive Multicenter Study.
Rui Batista, João Vinagre, Hugo Prazeres, Cristina Sampaio, Pedro Peralta

Front Genet· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liposomal therapies in oncology: does one size fit all?
Isabel Sousa, Filipa Rodrigues, Hugo Prazeres, Raquel T Lima, Paula Soares

Cancer Chemother Pharmacol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
WT1, MSH6, GATA5 and PAX5 as epigenetic oral squamous cell carcinoma biomarkers - a short report.
Ilda Patrícia Ribeiro, Francisco Caramelo, Francisco Marques, Ana Domingues, Margarida Mesquita, Hugo Prazeres

Cell Oncol (Dordr)· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro transforming potential, intracellular signaling properties and sensitivity to a kinase inhibitor (sorafenib) of RET proto-oncogene variants Glu511Lys, Ser649Leu and Arg886Trp.
Hugo Prazeres, Joana P Couto, Fernando Rodrigues, João Vinagre, Joana Torres

Endocr Relat Cancer· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The biology and the genetics of Hürthle cell tumors of the thyroid.
Valdemar Máximo, Jorge Lima, Hugo Prazeres, Paula Soares, Manuel Sobrinho-Simões

Endocr Relat Cancer· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "How to Treat a Signal? Current Basis for RET-Genotype-Oriented Choice of Kinase Inhibitors for the Treatment of Medullary Thyroid Cancer".
Hugo Prazeres, Joana Torres, Fernando Rodrigues, Joana P Couto, João Vinagre

J Thyroid Res· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Osteopontin expression is correlated with differentiation and good prognosis in medullary thyroid carcinoma.
Luciana Bueno Ferreira, Catarina Eloy, Ana Pestana, Joana Lyra, Margarida Moura, Hugo Prazeres

Eur J Endocrinol· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
mTOR activation in medullary thyroid carcinoma with RAS mutation.
Joana Lyra, João Vinagre, Rui Batista, Vasco Pinto, Hugo Prazeres

Eur J Endocrinol· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TERT promoter mutations are a major indicator of poor outcome in differentiated thyroid carcinomas.
Miguel Melo, Adriana Gaspar da Rocha, João Vinagre, Rui Batista, Joana Peixoto, Hugo Prazeres

J Clin Endocrinol Metab· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic imbalances detected by multiplex ligation-dependent probe amplification in a cohort of patients with oral squamous cell carcinoma-the first step towards clinical personalized medicine.
Ilda Patrícia Ribeiro, Francisco Marques, Francisco Caramelo, José Ferrão, Hugo Prazeres

Tumour Biol· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A polymorphism in the promoter region of the selenoprotein S gene (SEPS1) contributes to Hashimoto's thyroiditis susceptibility.
Liliana R Santos, Cecília Durães, Adélia Mendes, Hugo Prazeres, Maria Inês Alvelos

J Clin Endocrinol Metab· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic gains and losses in oral squamous cell carcinoma: impact on clinical management.
Ilda Patrícia Ribeiro, Francisco Marques, Francisco Caramelo, João Pereira, Miguel Patrício, Hugo Prazeres

Cell Oncol (Dordr)· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Frequency of TERT promoter mutations in human cancers.
João Vinagre, Ana Almeida, Helena Pópulo, Rui Batista, Joana Lyra, Hugo Prazeres

Nat Commun· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis